L., Wong, J., Northcott, M
multiple agent therapy wherein each agent is independently a sub-therapeutic dose, with either sequential or concurrent administration of the agents, will produce the desired pharmacological response, such as an erection sufficient for sexual intercourse, without producing the frequency or severity of adverse side effects observed at a sufficiently high dose of either agent administered as monotherapy that produces a comparable pharmacological response
In the SURPASS clinical trial program, which enrolled over 6,000 participants with type 2 diabetes, the most common side effects included nausea (reported in 12% to 29% of patients), diarrhea (13% to 16%), vomiting (5% to 10%), constipation (6% to 7%), and abdominal discomfort
Melanotan II, also known as the "Barbie drug," is marketed online primarily as a sunless tanning agent but was originally developed by the University of Arizona as a preventative therapy for skin cancer
It should be noted that this use should only be considered under the guidance of a doctor
